Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

Chest. 1999 Sep;116(3):595-602.

PMID:
10492259
2.

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.

JAMA. 1994 May 11;271(18):1412-6.

PMID:
7909853
3.

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.

N Engl J Med. 1992 Oct 22;327(17):1198-203.

4.

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.

Kalra S, Swystun VA, Bhagat R, Cockcroft DW.

Chest. 1996 Apr;109(4):953-6.

PMID:
8635376
5.

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.

FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):427-35.

PMID:
10069876
7.

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.

Yates DH, Kharitonov SA, Barnes PJ.

Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1603-7. Erratum in: Am J Respir Crit Care Med 1997 Apr;155(4):1491.

PMID:
8970342
9.

Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.

Yates DH, Worsdell M, Barnes PJ.

Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):988-91.

PMID:
9310023
10.
13.

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA.

J Allergy Clin Immunol. 1999 Jun;103(6):1075-80.

PMID:
10359889
14.

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.

Bronsky EA, Kemp JP, Orgel HA, Bierman CW, Tinkelman DG, van As A, Liddle RF.

Chest. 1994 Apr;105(4):1032-7.

PMID:
7909285
15.

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.

Boulet LP, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.

Eur Respir J. 1998 May;11(5):1091-7.

18.

A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine.

Kemp JP, DeGraff AC Jr, Pearlman DS, Wang Y, Arledge TE, Welch MB, O'Riordan TG, Herrle MR, Stahl EG.

J Allergy Clin Immunol. 1999 Dec;104(6):1189-97.

PMID:
10589000
19.

Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.

Verberne AA, Hop WC, Bos AB, Kerrebijn KF.

J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):127-34.

PMID:
8093705
20.

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Kemp JP, Cook DA, Incaudo GA, Corren J, Kalberg C, Emmett A, Cox FM, Rickard K.

J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):188-95.

PMID:
9500751
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk